Sage Journals: Discover world-class research

Abstract

Objective:

Repeated surgical interventions are usually required to control recurrent respiratory papillomatosis (RRP), but at considerable risk of worsened postoperative voice quality. Potassium titanyl phosphate (KTP) laser has been reported to effectively manage RRP; however, voice quality after repeated procedures has not been investigated.

Methods:

This study recruited 16 patients with RRP treated using KTP laser between 2013 and 2019. KTP laser procedures were performed under general anesthesia via direct suspension laryngoscope or under local anesthesia via flexible endoscope, depending on the need for pathological proof, patient tolerance, and lesion size and location. Disease control was investigated by videolaryngostroboscopy. Voice outcome was evaluated using a 10-item voice handicap index (VHI-10), acoustic and perceptual analyzes.

Results:

We reviewed the medical records of 11 male and 5 female patients with RRP (age range: 23-73 years). Five patients received KTP laser once, six patients received it 2 to 5 times, and five patients received 6 to 15 procedures. Median VHI-10 decreased from 28.3 to 12.0 points after the initial procedure and were maintained at 10.1 to 11.0 points following subsequent procedures (P < .01, generalized estimating equation). Acoustic and perceptual analysis of voice quality also revealed significant improvements (P < .01), which remained stable even after 6 to 10 KTP laser procedures. Minor adverse events included slight fibrotic change of vocal folds and glottic web, but these did not significantly alter postoperative voice quality.

Conclusion:

This longitudinal follow-up study revealed that serial KTP laser procedures can effectively control RRP while preserving phonatory function and maintaining adequate voice quality.

Level of Evidence:

Keywords

larynx voice office procedure angiolytic laser

Get full access to this article

View all access options for this article.

References

Bzhalava

Guan

Franceschi

Dillner

Clifford

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445(1-2):224-231.

Omland

Akre

Vardal

Brondbo

Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122(7):1595-1599.

Kashima

Mounts

Leventhal

Hruban

RH.

Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1993;102(8 pt 1):580-583.

Ivancic

Iqbal

deSilva

Pan

Matrka

Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22-34.

Kirstein

Autoscopy of the larynx and trachea. Arch Laryngol Rhinol. 1895;3:156-164.

Jackson

Killian

Hageman

Peroral Endoscopy and Laryngeal Surgery. St Louis, MO: Laryngoscope Company; 1915.

Patel

CKN

. Continuous-wave laser action on vibrational-rotational transitions of CO₂. Phys Rev. 1964;136(5A):A1187.

Hirano

Clinical examination of voice. Disord Hum Commun. 1981;5:1-99.

Mouadeb

Belafsky

PC.

In-office laryngeal surgery with the 585 nm pulsed dye laser (PDL). Otolaryngol Head Neck Surg. 2007;137(3):477-481.

10.

Burns

Zeitels

Akst

Broadhurst

Hillman

Anderson

532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia. Laryngoscope. 2007;117(8):1500-1504.

11.

Zeitels

Akst

Burns

Hillman

Broadhurst

Anderson

RR.

Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006;115(9):679-685.

12.

Rees

Postma

Koufman

. Cost savings of unsedated office-based laser surgery for laryngeal papillomas. Ann Otol Rhinol Laryngol. 2007;116(1):45–48.

13.

Dedo

KC.

CO₂ laser treatment in 244 patients with respiratory papillomas. Laryngoscope. 2001;111(9):1639-1644.

14.

Rasmussen

Schnack

Jorkov

Raja

Olsen

Homoe

Long-term follow-up and outcome in patients with recurrent respiratory laryngeal papillomatosis. Dan Med J. 2017;64(12):A5424.

15.

Jackowska

Wojnowski

Hashimoto

, et al. Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO₂ laser surgery. Lasers Med Sci. 2019;34(7):1433-1440.

16.

Derkay

Malis

Zalzal

Wiatrak

Kashima

Coltrera

MD.

A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998;108(6):935-937.

17.

Cohen

SR.

Congenital glottic webs in children: a retrospective review of 51 patients. Ann Otol Rhinol Laryngol. 1985;94(suppl 6):2-16.

18.

Lin

Wang

Lin

Liao

Cheng

PW.

Treatment outcomes and adverse events following in-office angiolytic laser with or without concurrent polypectomy for vocal fold polyps. JAMA Otolaryngol Head Neck Surg. 2018;144(3):222-230.

19.

Mallur

Johns

III Amin

Rosen

CA.

Proposed classification system for reporting 532-nm pulsed potassium titanyl phosphate laser treatment effects on vocal fold lesions. Laryngoscope. 2014;124(5):1170-1175.

20.

Wang

Liao

Huang

Cheng

PW.

Comparison of treatment outcomes of transnasal vocal fold polypectomy versus microlaryngoscopic surgery. Laryngo-scope. 2015;125(5):1155-1160.

21.

Rosen

Gartner-Schmidt

Hathaway

, et al. A nomenclature paradigm for benign midmembranous vocal fold lesions. Laryngoscope. 2012;122(6):1335-1341.

22.

Hsu

Y-C

Liao

L-J

Huang

T-W

Wang

C-T.

Assessment of patient outcomes after adjuvant vocal fold steroid injection for fibrosis after microlaryngeal surgery. JAMA Otolaryngol Head Neck Surg. 2019;145(9):811-816.

23.

Rosen

Lee

Osborne

Zullo

Murry

Development and validation of the voice handicap index-10. Laryngoscope. 2004;114(9):1549-1556.

24.

Lam

Chan

Kwong

Yiu

Wei

WI.

Cross-cultural adaptation and validation of the Chinese Voice Handicap Index-10. Laryngoscope. 2006;116(7):1192-1198.

25.

Hsu

Y-C

Lin

F-C

Wang

C-T.

Optimization of the minimal clinically important difference of the Mandarin Chinese version of 10-item voice handicap index. J Taiwan Otolaryngol Head Neck Surg. 2017;52(1):8-14.

26.

Heman-Ackah

Heuer

Michael

, et al. Cepstral peak prominence: a more reliable measure of dysphonia. Ann Otol Rhinol Laryngol. 2003;112(4):324-333.

27.

De Clercq

Descamps

De Somer

Holý

. (S)-9-(2, 3-Dihydroxypropyl) adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity. Science. 1978;200(4341):563-565.

28.

Leventhal

Kashima

Weck

, et al. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg. 1988;114(10):1163-1169.

29.

Healy

Gelber

Trowbridge

Grundfast

Ruben

Price

KN.

Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. N Engl J Med. 1988;319(7):401-407.

30.

Rosen

Bryson

PC.

Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice. 2004;18(2):248-253.

31.

Carifi

Napolitano

Morandi

Dall’Olio

. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. 2015;11:731-738.

32.

Benboujja

Bowe

Boudoux

Hartnick

Utility of optical coherence tomography for guiding laser therapy among patients with recurrent respiratory papillomatosis. JAMA Otolaryngol Head Neck Surg. 2018;144(9):831-837.

33.

Rosen

Simpson

CB.

Operative Techniques in Laryngology. Berlin: Springer Science & Business Media; 2008.

34.

Broadhurst

Akst

Burns

, et al. Effects of 532 nm pulsed-KTP laser parameters on vessel ablation in the avian chorioallantoic membrane: implications for vocal fold mucosa. Laryngoscope. 2007;117(2):220-225.

35.

Gray

Pignatari

Harding

Morphologic ultrastructure of anchoring fibers in normal vocal fold basement membrane zone. J Voice. 1994;8(1):48-52.

36.

Benedict

Garber

Wang

Amin

Branski

RC.

Laryngeal distribution of adult-onset recurrent respiratory papillomatosis: a longitudinal study. Laryngoscope. 2019;129(9):1993-1997.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis

Abstract

Objective:

Methods:

Results:

Conclusion:

Level of Evidence:

Keywords

Get full access to this article

References

Supplementary Material